Ramsi Pharmaceuticals Private Limited - Company Profile

It is a trading private limited company based in Ranchi, Jharkhand, India, established in 2019.
2019 Ranchi, Jharkhand, India Active
Last Updated:
About Ramsi Pharmaceuticals Private Limited

Ramsi Pharmaceuticals Private Limited, a active private limited company, was established on 10 December 2019 in Ranchi, Jharkhand, India. Engaging in specialty within the trading sector, it holds CIN: U51909JH2019PTC013762. Registered under ROC Roc Ranchi. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.48 M.

Its leadership includes Mohammad Irshad Quraishi (Director), Shubham Sharma (Director), Nadeem Ahmad (Director). Past directors included Shubham Sharma, Nadeem Ahmad. It is based at 34 Pathar Road Mani Tola, Doranda, Ranchi, Jharkhand, 834002.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U51909JH2019PTC013762

  • Registration Number

    013762

  • Incorporation Date

    10 December 2019

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.48 M

  • ROC Code

    Roc Ranchi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.48 M
  • Company Age 6 Year, 3 Months
Company report

Ramsi Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Ramsi Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Ramsi Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Mohammad Irshad Quraishi Director 10 Dec 2019 Current
Shubham Sharma Director 10 Dec 2019 Current
Nadeem Ahmad Director 10 Dec 2019 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 07 Oct 2020 Past
Pramod Abcsdd Director 07 Oct 2020 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Ramsi Pharmaceuticals.

Enhance accessibility to Ramsi Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Ramsi Pharmaceuticals revenue growth over time
Ramsi Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Ramsi Pharmaceuticals?

Unlock access to Ramsi Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Ramsi Pharmaceuticals?

Unlock and access historical data on people associated with Ramsi Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Ramsi Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ramsi Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Ramsi Pharmaceuticals
Recent Activity within the Organization
  • Director Appointment

    Mohammad Irshad Quraishi was appointed as a Director was appointed as a Director on 10 Dec 2019 & has been associated with this company since 6 years 3 months . was recorded as a recent event.

  • Director Appointment

    The activity Shubham Sharma was appointed as a Director was appointed as a Director on 10 Dec 2019 & has been associated with this company since 6 years 3 months . was completed.

  • Director Appointment

    Progress on Nadeem Ahmad was appointed as a Director was appointed as a Director on 10 Dec 2019 & has been associated with this company since 6 years 3 months . was documented.

  • Company Incorporation

    Ramsi Pharmaceuticals Private Limited was registered on 10 Dec 2019 with Roc Ranchi & aged 6 years 3 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Ramsi Pharmaceuticals Private Limited?

The CIN of Ramsi Pharmaceuticals Private Limited is U51909JH2019PTC013762.

Where is Ramsi Pharmaceuticals Private Limited headquartered?

Ramsi Pharmaceuticals Private Limited is headquartered at 34 Pathar Road Mani Tola, Doranda, Ranchi, Jharkhand, 834002.

When was Ramsi Pharmaceuticals Private Limited incorporated?

Ramsi Pharmaceuticals Private Limited was incorporated on 10 December 2019.

Who are the current directors of Ramsi Pharmaceuticals Private Limited?

The current directors of Ramsi Pharmaceuticals Private Limited are

What is the primary industry of Ramsi Pharmaceuticals Private Limited?

The primary industry of Ramsi Pharmaceuticals Private Limited is Trading.

Is Ramsi Pharmaceuticals Private Limited a listed company?

Ramsi Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Ramsi Pharmaceuticals Private Limited?

The authorized capital of Ramsi Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.48 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available